Background/Aims: Liver stellate cell proliferation and differentiation
into myofibroblast-like cells is related to the development of liver
fibrosis, Several cytokines, including interferons, regulate liver ste
llate cell proliferation and phenotypic modulation, Recent studies ind
icate that human liver stellate cells express the alpha-isotype of act
in, specific to smooth muscle cell differentiation. We aimed to evalua
te the expression of alpha-smooth muscle actin-positive liver stellate
cells in patients with chronic viral hepatitis and to evaluate whethe
r and how such expression can be modified by a-interferon treatment. M
ethods: Using immunohistochemistry and a semi-quantitative scoring met
hod, we evaluated alpha-smooth muscle actin expression in liver stella
te cells before and after alpha-interferon therapy in a series of live
r biopsies from 44 patients with chronic viral hepatitis. Results: Bef
ore therapy, a large number of liver stellate cells expressing alpha-s
mooth muscle actin were present throughout all acinar zones. A signifi
cant reduction in alpha-smooth muscle actin expression by liver stella
te cells was demonstrated in biopsies performed after suspending the i
nterferon treatment. The drop in the number of alpha-smooth muscle act
in-labelled cells after therapy correlated closely with the improvemen
t in the histological index of activity. Conclusions: The results sugg
est a specific effect of interferon on liver stellate cells, possibly
related to its anti-inflammatory action.